INVENTING A NEW
                      ROADMAP FOR BIOTECH

                      Every day, we use our homegrown technologies to discover, develop, research and deliver new medicines that help people with serious diseases. Watch to see what drives us.

                      Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.

                      Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.

                      FOR 30+ YEARS, OUR
                      MISSION HAS BEEN TO
                      USE THE POWER OF
                      SCIENCE TO BRING
                      NEW MEDICINES TO
                      PATIENTS... OVER
                      AND OVER AGAIN.

                      Neil Stahl, PhD, Executive VP,
                      Research and Development
                      2019 annual report PDF download

                      Check out our 2019 annual materials. The Responsibility Report and Annual Report are now online.

                      Read our annual report
                      and responsibility report

                      2019 responsibility report PDF download

                      REGENERON BY THE NUMBERS

                      • 30+
                        years of scientific
                        leadership
                      • 8,100+
                        employees
                        worldwide
                      • ~1,100+
                        employees with
                        an MD, PhD or
                        PharmD degree
                      • 6TH
                        consecutive year
                        in Forbes’ World’s
                        Most Innovative
                        Companies
                      • #1
                        ranking in Science
                        magazine’s global Top
                        Employer survey for six
                        of the past nine years
                      • 31,000+
                        employee volunteer hours
                        for 100+ organizations
                        in 2018
                      • 7
                        FDA-approved
                        medicines
                      • 98%
                        of our waste
                        diverted from
                        landfill, surpassing
                        our goal
                      • 100%
                        of drug candidates
                        invented and
                        developed in-house
                      • 1M+
                        exomes sequenced
                        to date
                      • 200+
                        peer-reviewed publications
                        in 2019
                      • 20+
                        product candidates in
                        clinical development
                        across multiple
                        therapeutic areas
                      • Fortune: Best Companies to Work for, 2020

                        Newsweek, America’s Most Responsible Companies, 2020

                        IDEA Pharma, Pharmaceutical Invention Index, 2019

                        RobecoSAM and S&P Dow Jones Indices: Dow Jones Sustainability World Index, 2019

                        Science: Top Employer, 2019

                        Harvard Business Review: Best Performing CEOs, 2019

                      • Civic 50: Most Community-Minded Companies in the Nation, 2019

                        Fast Company: Best Workplaces for Innovators, 2019

                        Shingo Institute: The Shingo Prize, 2019

                        Great Places to Work: Best Workplace in Ireland, 2019

                        Forbes: Top 10 Most Innovative Companies, 2018

                      LEADERSHIP

                      We are the only biopharmaceutical company to be led by physician-scientists for more than 30 years. We consistently demonstrate our commitment to scientific excellence by counting multiple Nobel Laureates and five members of the National Academy of Sciences among our leadership, as well as being one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard.

                      Our leadership

                      A FOCUS
                      ON SCIENCE

                      From our first days, science has remained our central guiding principle.

                      Our journey
                      国产一级毛片在线播放